Docetaxel

Țară: Noua Zeelandă

Limbă: engleză

Sursă: Medsafe (Medicines Safety Authority)

Ingredient activ:

Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg

Disponibil de la:

REX Medical Ltd

INN (nume internaţional):

Docetaxel trihydrate 100.71 mg (equivalent to anhydrous docetaxel 80 mg)

Dozare:

80 mg/mL

Forma farmaceutică:

Concentrate for infusion

Compoziție:

Active: Docetaxel trihydrate 100.71mg equivalent to anhydrous docetaxel 80 mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

Unități în pachet:

Vial, glass, Diluent, 6 mL

Clasă:

Prescription

Tip de prescriptie medicala:

Prescription

Produs de:

Cipla Ltd

Indicații terapeutice:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Rezumat produs:

Package - Contents - Shelf Life: Vial, glass, Diluent - 6 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 80 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Data de autorizare:

2006-06-23